About ATDBio
ATDBio is a Healthcare company based in Southampton (United Kingdom) founded in 2005 by Tom Brown, and was acquired by Biotage in October 2021. Developer of oligonucleotides. The company has 23 employees. Its website atdbio.com draws about 29 thousand monthly visits. ATDBio offers products and services including Oligonucleotide Synthesis, Oligo Calculator, and Nucleic Acids Book. Its focus areas include Life Sciences, Life Sciences Platforms and Tools, Research Reagents and Kits and Probes and Dyes. Its legal entity is ATDBIO LIMITED.
Company details
ATDBio was founded in 2005 and is headquartered in Southampton, United Kingdom. Customised DNA oligonucleotides are developed by the company within the biotechnology sector. Operations focus on producing oligos, fluorescent probes, and long oligos. These products are supplied for applications in research and diagnostic kits. The founder, Tom Brown, leads the efforts in oligonucleotide development.
- Headquarters Southampton, United Kingdom
- Employees 23
- Founders Tom Brown
- Stage Acquired
- SectorsHealthcare
- Phone•••• ••••
- Website atdbio.com
- Social LinkedIn X Facebook
- Acquired by Biotage (Oct 2021)
- Legal Name Atdbio Limited
- Date of Incorporation 03 Dec, 2004
- Jurisdiction YSTRAD MYNACH, HENGOED, WALES
Products & Services of ATDBio
ATDBio offers a comprehensive portfolio of products and services, including Oligonucleotide Synthesis, Oligo Calculator, and Nucleic Acids Book.
Custom design and synthesis of oligonucleotides for research and diagnostics
Online tool for calculating oligonucleotide properties and applications
Free online resource on nucleic acid chemistry and biology
Funding Insights of ATDBio
- Total Rounds 5
- Last Round Grant — $436,020
- First Round $330,367
(Jan 2015)
- Investors Count 2
All 5 funding rounds of ATDBio with amounts and investors; the two latest post-money valuations are shown, the rest are part of the premium plan.
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Sep 2020 | $436,020 | Grant | – | – | |
| Apr 2020 | $338,311 | Grant | – | – | |
| Jan 2020 | $338,311 | Grant | – | – | |
| Jan 2018 | $328,243 | Grant | – | – | |
| Jan 2015 | $330,367 | Grant | – | – |
3 investors in total: 3 institutional.
Investors in ATDBio
ATDBio has secured backing from 3 investors, including institutional investors. Prominent investors backing the company include Biotage, European Union and Innovate UK.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
| innovateuk.gov.uk | ||||
Government entites focused on freedom, democracy, equality and the rule of law, promoting peace and stability | 1958 | europa.eu | Brussels, Belgium | |
Organic synthesis, analytical, and peptide chemistry services for drug discovery and development | 2009 | biotage.com | Uppsala, Sweden |
Investor details for ATDBio
The complete investor list, round-by-round participation and investor portfolios require an active premium plan.
- Complete investor list
- Round participation
- Investor portfolios
- Co-investor network
Verified entity values are shown only after access is granted.
People of ATDBio
1 people are tracked at ATDBio (1 in leadership); the tracked headcount is 23.
| Name | Role | Group |
|---|---|---|
Tom Brown | Founder | Leadership |
Complete people profiles for ATDBio
Full employee and board profiles, team structure, tenure and professional contact details require an active premium plan.
- Full employee list
- Team structure
- Board tenure
- Professional contacts
Verified entity values are shown only after access is granted.
Timeline of ATDBio
4 dated milestones of ATDBio across 16 years, from founding to its latest funding, stage changes and deals.
- Founded ATDBio is founded.
- Funding First funding round of $330K.
- Funding Latest funding round, Grant, of $436K.
- Exit Acquired by Biotage.
Web traffic of ATDBio
The website of ATDBio (atdbio.com) receives about 29.3K visits a month.
- Monthly visits29.3K
▼ 2.3% vs previous month
Websites whose visitors overlap most with ATDBio. Affinity shows how closely the audiences match.
| Website | Domain | Audience affinity | Monthly visits | Global rank | Profile |
|---|---|---|---|---|---|
| meliorum.com | 100% | View details | |||
| altairnano.com | 99% | 1.7K | #9,586,548 | View details | |
| noblepolymers.com | 91% | View details | |||
| crystalplex.com | 78% | View details | |||
nanomaterialscompany.com | nanomaterialscompany.com | 76% | – | ||
| •••••••••• | ••••••.com | ••% | •.•M | #••••• | – |
| •••••••••• | ••••••.com | ••% | •.•M | #••••• | – |
| •••••••••• | ••••••.com | ••% | •.•M | #••••• | – |
All 9 similar websites and full traffic analytics for ATDBio
The complete similar-websites list, audience overlap and engagement analytics require an active premium plan.
- 9 similar websites
- Audience overlap
- Engagement analytics
- Traffic by brand
Verified entity values are shown only after access is granted.
Top companies in Life Sciences Platforms & Tools
3 companies that operate in the same segment as ATDBio (Life Sciences Platforms & Tools) in United Kingdom, ranked by their profile score on The Company Check.
| Company | Description | Founded | Location | Total funding | Revenue | Employees |
|---|---|---|---|---|---|---|
Nanopore-based electronic systems for single-molecule analysis are developed. | 2005 | Oxford, Oxfordshire, United Kingdom | USD 1.34 B | USD 301.49 M | 1,372 | |
Genetically modified cell lines are developed using AAV gene-editing platform. | 2007 | Cambridge, Cambridgeshire, United Kingdom | USD 46.29 M | |||
Biological reagents and antibodies are developed for life science research. | 1998 | Cambridge, Cambridgeshire, United Kingdom | USD 78.8 M |
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Related news about Atdbio
Complete news archive for ATDBio
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about ATDBio
ATDBio was founded in 2005 and raised its 1st funding round 10 years after it was founded.
ATDBio is headquartered in Southampton, United Kingdom.
ATDBio has 23 employees.
ATDBio was founded in 2005 and is headquartered in Southampton, United Kingdom. Customised DNA oligonucleotides are developed by the company within the biotechnology sector. Operations focus on producing oligos, fluorescent probes, and long oligos. These products are supplied for applications in research and diagnostic kits. The founder, Tom Brown, leads the efforts in oligonucleotide development.
ATDBio offers Oligonucleotide Synthesis, Oligo Calculator, and Nucleic Acids Book.
ATDBio has 3 investors. Key investors include Biotage, European Union, and Innovate UK.
ATDBio operates through Atdbio Limited.
Yes. ATDBio was acquired by Biotage in October 2021.